City

Bethesda (1)

Condition

Eosinophilic Myeloid Neoplasm (1)

Hypereosinophilic Syndrome (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

imatinib (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

eosinophilic myeloid neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting

Eosinophilic Myeloid Neoplasm
Hypereosinophilic Syndrome

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 25, 2023